BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 29, 2021
View Archived Issues
Chengdu Baiyu Pharmaceutical presents new tetrahydrocannabinol derivatives
Read More
New RORgammaT agonists identified at Sunshine Lake Pharma
Read More
Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent PD-1/PD-L1 inhibitors
Read More
First patients dosed in new studies of Xpovio in melanoma and myelofibrosis
Read More
FDA authorizes phase II study of autologous adipose-derived mesenchymal stem cells in MS
Read More
Vonafexor meets primary endpoint in the phase IIa LIVIFY study in patients with NASH
Read More
New serine-protein kinase ATM inhibitors described by Medshine Discovery
Read More
ISIS-814907 well tolerated in first-in-human study in mild Alzheimer's disease patients
Read More
MMV-688533 shows excellent single-dose efficacy in P. falciparum-infected mouse model
Read More
Selinexor shows antiviral and the anti-inflammatory effects in models of SARS-CoV-2 infection
Read More
Phase II study of CETP inhibitor obicetrapib meets primary endpoint
Read More
IDMC of phase II study of EscharEx for venous leg ulcers recommends continuation of trial
Read More
Targeting the IL-8/CXCR2 axis as a potential therapeutic strategy in prostate cancer
Read More
New phase Ib/II trial evaluates pembrolizumab combination therapies in second-line ES-SCLC
Read More
Venatorx reports phase I data on beta-lactamase inhibitor VNRX-7145
Read More
Arcturus cleared to begin phase II study of ARCT-810 for OTC deficiency
Read More
Clarity initiates phase I/IIa theranostic trial of 64/67Cu SAR-bisPSMA in metastatic CRPC
Read More
Restoring chondroitin 6-sulfate can rescue age-related memory impairment
Read More
Daewoong reports phase IIb topline data on Foistar in mild COVID-19
Read More
FDA clears INDs for targeted alpha therapy FPI-1966 and imaging agent FPI-1967
Read More
Blueprint Medicines and MD Anderson collaborate on advancing CDK2 inhibitor BLU-222
Read More